Prevalence of Primary Drug Resistance-Associated Mutations Among HIV Type 1 Vertically Infected Children in Belo Horizonte, Brazil

2010 ◽  
Vol 26 (2) ◽  
pp. 229-232 ◽  
Author(s):  
F.G.F. Ferreira ◽  
J.A. Pinto ◽  
F.M. Kakehasi ◽  
S. Cleto ◽  
U. Tupinambás ◽  
...  
2011 ◽  
Vol 27 (10) ◽  
pp. 1047-1053 ◽  
Author(s):  
Bin Zhao ◽  
Xiaoxu Han ◽  
Di Dai ◽  
Jing Liu ◽  
Haibo Ding ◽  
...  

2020 ◽  
Vol 18 (3) ◽  
pp. 210-218
Author(s):  
Guolong Yu ◽  
Yan Li ◽  
Xuhe Huang ◽  
Pingping Zhou ◽  
Jin Yan ◽  
...  

Background: HIV-1 CRF55_01B was first reported in 2013. At present, no report is available regarding this new clade’s polymorphisms in its functionally critical regions protease and reverse transcriptase. Objective: To identify the diversity difference in protease and reverse transcriptase between CRF55_01B and its parental clades CRF01_AE and subtype B; and to investigate CRF55_01B’s drug resistance mutations associated with the protease inhibition and reverse transcriptase inhibition. Methods: HIV-1 RNA was extracted from plasma derived from a MSM population. The reverse transcription and nested PCR amplification were performed following our in-house PCR procedure. Genotyping and drug resistant-associated mutations and polymorphisms were identified based on polygenetic analyses and the usage of the HIV Drug Resistance Database, respectively. Results: A total of 9.24 % of the identified CRF55_01B sequences bear the primary drug resistance. CRF55_01B contains polymorphisms I13I/V, G16E and E35D that differ from those in CRF01_AE. Among the 11 polymorphisms in the RT region, seven were statistically different from CRF01_AE’s. Another three polymorphisms, R211K (98.3%), F214L (98.3%), and V245A/E (98.3 %.), were identified in the RT region and they all were statistically different with that of the subtype B. The V179E/D mutation, responsible for 100% potential low-level drug resistance, was found in all CRF55_01B sequences. Lastly, the phylogenetic analyses demonstrated 18 distinct clusters that account for 35% of the samples. Conclusions: CRF55_01B’s pol has different genetic diversity comparing to its counterpart in CRF55_01B’s parental clades. CRF55_01B has a high primary drug resistance presence and the V179E/D mutation may confer more vulnerability to drug resistance.


2009 ◽  
Vol 13 (5) ◽  
pp. 577-583 ◽  
Author(s):  
Harout K. Tossonian ◽  
Jesse D. Raffa ◽  
Jason Grebely ◽  
Mark Viljoen ◽  
Annabel Mead ◽  
...  

2013 ◽  
Vol 29 (1) ◽  
pp. 129-135 ◽  
Author(s):  
Amin S. Hassan ◽  
Shalton M. Mwaringa ◽  
Clare A. Obonyo ◽  
Helen M. Nabwera ◽  
Eduard J. Sanders ◽  
...  

2011 ◽  
Vol 27 (12) ◽  
pp. 1283-1290 ◽  
Author(s):  
Anne Margrethe Audelin ◽  
Jan Gerstoft ◽  
Niels Obel ◽  
Lars Mathiesen ◽  
Alex Laursen ◽  
...  

2016 ◽  
Vol 06 (03) ◽  
pp. 111-115
Author(s):  
Anoumou Dagnra ◽  
Abla Konou ◽  
Mounerou Salou ◽  
Pascal Kodah ◽  
Damobé Kombate ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document